General
EC aspirin tied to high nonresponsiveness in patients with diabetes
 

EC aspirin tied to high nonresponsiveness in patients with diabetes

Shared by:

 
Treatment with enteric-coated (EC) aspirin does not completely inhibit serum thromboxane B2 (TXB2) generation in a high proportion of patients with diabetes due to incomplete absorption, according to a new study.
 
specialty.mims.com
 
14 Feb 2017 - General